ClinicalTrials.Veeva

Menu

Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache

N

Norwegian University of Science and Technology

Status

Withdrawn

Conditions

Mental Disorders

Treatments

Drug: Ibuprofen

Study type

Interventional

Funder types

Other

Identifiers

NCT00258791
LVS-2005

Details and patient eligibility

About

The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.

Full description

The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.

Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.

Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up [5].

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients receiving ECT

Exclusion criteria

  • Pregnancy, contraindications to ibuprofen

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems